URGNCIK 1668243

UroGen Pharma Ltd.

EDGAR filings

Customers

None disclosed

Suppliers

1 disclosed

Latest period

Dec 31, 2025

10-K filed 2026-03-02

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Suppliers 1

Companies that disclose URGN as a major customer, as a share of their own revenue. 1 active, 0 lapsed.

Company	% of their revenue	Est. $ from URGN	Period	Trend	Status	Source
Isotopia Molecular Imaging Ltd. Non-SEC Isotopia Molecular Imaging Ltd.	Named	—	FY 2025-12-31	—	Active	10-K 2026-03-02
Our research and development facility is located in Ra’anana, Israel, and certain of our key vendors and suppliers, including Isotopia Molecular Imaging Ltd., our single contracted supplier for the hydrogel contained in Jelmyto and Zusduri, are located in Israel. 10-K filed 2026-03-02 Period FY 2025-01-01 to 2025-12-31Accession 0001437749-26-006234

Alerts are coming

Get an email when URGN's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.